17th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Target List csv
Targets are released at 9:30 am Pacific time (PDT=GMT-7hours) and expire at 9:00 am PDT.

Predictions in special categories, where a large number of models is requested, should be submitted before the Soft Deadline (typically 2 days before the Human Expiration) as submissions in these categories will not be checked immediately upon acceptance, but shortly afterwards. If model(s) have formatting issues, you will get a message from us within a few hours after the Soft Deadline so that you will have a chance to resubmit models before the Human Expiration deadline.

Green color - active target; Yellow color - target expires within 48 hours; Orange color - target expires within 24 hours
Nucleic acid-containing complexes are highlighted with the light grey background.

Target type 'h' is for human targets, 's' for server-only targets.
Target naming convention: Txxxx - protein monomers/homomers; Hxxxx - protein heteromers; Rxxxx - RNA monomers/homomers; Dxxxx - DNA monomers/homomers; Mxxxx (hybrid) - nucleic acid-containing hetero-complexes (with or without protein); Lxxxx - ligand only targets.
Stoichiometry 'UNK' stands for UNKNOWN.
* CAPRI target

All targets Mono/Homo -mers Multimers RNA Ligand Ensemble
Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all
#
Tar-id
Type
Res
Stoichiom.
Entry    
Date
Server
Expiration
Soft
Deadline
Human
Expiration
QA
Prediction
Description
1. R2301 s NucA 96 A1 2026-04-27 2026-04-29 2026-04-29 2026-04-29 - Eterna JR_UC2199_030
2. R2302 s NucA 90 A1 2026-04-27 2026-04-29 2026-04-29 2026-04-29 - Eterna PK90_14 f39
3. H1311 * h Prot 822 A1B1C1D1E1 2026-04-28 2026-05-02 2026-05-13 2026-05-13 from: 2026-05-13
to: 2026-05-16
NRAS17.3.2_Q61K_HLAA1
4. R2303 s NucA 84 A2 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Eterna ZG_113_EliFisker_F_10
5. R2304 s NucA 100 A1 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Struct2SeQ SHAPE design
6. H1312 h Prot 1409 UNK 2026-04-29 2026-05-02 2026-05-13 2026-05-13 - EXT1-EXT2-2BAV4
7. R2305 s NucA 105 A2 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-RFdiff design
8. R2306 s NucA 100 A1 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-fixbb design
9. R2307 s NucA 100 A1 2026-04-30 2026-05-02 2026-05-02 2026-05-02 - gRNAde design
10. R2308 s NucA 93 A1 2026-04-30 2026-05-02 2026-05-02 2026-05-02 - Triphosphorylation ribozyme
11. T1313 h Prot 618 UNK 2026-04-30 2026-05-03 2026-05-14 2026-05-14 - P66
12. M2310 s Hybrid /Ensmbl 810 A1B1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
13. R2309 s NucA /Ensmbl 810 A1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron precat
14. R2310 s NucA /Ensmbl 788 A1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
15. R2314 s NucA/Ligand /Ensmbl 25 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - Tryptophan binding aptamer holo
16. R2315 s NucA /Ensmbl 25 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - Tryptophan binding aptamer apo
17. R2316 s NucA 97 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - miniTTR GNRA tetraloop/receptor
18. H1319 h Prot 497 UNK 2026-05-05 2026-05-08 2026-05-19 2026-05-19 - Human astrovirus VA1 capsid spike - antibody 7C8 complex
19. R2317 s NucA/Ligand 129 A1 2026-05-05 2026-05-07 2026-05-07 2026-05-07 - Lmo Glycine riboswitch holo
20. R2318 s NucA/Ligand 140 A1 2026-05-05 2026-05-07 2026-05-07 2026-05-07 - Dha Glycine riboswitch holo
21. H1321 h Prot 502 UNK 2026-05-06 2026-05-09 2026-05-20 2026-05-20 - Human astrovirus VA1 capsid spike - antibody 2A2 complex
22. M2320 s Hybrid 731 A1B1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
23. R2320s0 s NucA 731 A1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
24. H2324 * h Prot 856 A1B1C1D1E1 2026-05-07 2026-05-10 2026-05-21 2026-05-21 from: 2026-05-21
to: 2026-05-24
T Cell Receptor N17.2, complex (5 chains)
25. R2322 s NucA /Ensmbl 83 A1 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 monomer mutant
26. R2323 s NucA /Ensmbl 83 A2 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 WT
27. R2325 s NucA 499 A2 2026-05-08 2026-05-11 2026-05-11 2026-05-11 - O.i. group II intron dimer
28. H1332 h Prot 704 UNK 2026-05-11 2026-05-14
canceled on
2026-05-18
2026-05-25
canceled on
2026-05-18
2026-05-25
canceled on
2026-05-18
- Fab 047-09_1A02 binding influenza virus H1 HA
Canceled - preprint.
29. R2326 s NucA/Ligand 37 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Arginine binding aptamer
30. R2327 s NucA/Ligand 40 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Histidine binding aptamer
31. R2328 s NucA/Ligand 32 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Isoleucine binding aptamer
32. R2329 s NucA/Ligand 60 A1 2026-05-12 2026-05-14 2026-05-14 2026-05-14 - SAMURI ribozyme holo
33. R2330 s NucA/Ligand 75 A1 2026-05-12 2026-05-14 2026-05-14 2026-05-14 - TPP riboswitch holo
34. T1331 h Prot 281 UNK 2026-05-12 2026-05-15 2026-05-26 2026-05-26 - 5AT
35. H1335 h Prot 1820 UNK 2026-05-13 2026-05-16 2026-05-27 2026-05-27 - HCMV Merlin gHgLgO-Fab complex
36. H2312 * h Prot 1409 A1B1C1 2026-05-13 2026-05-16 2026-05-27 2026-05-27 from: 2026-05-27
to: 2026-05-30
EXT1-EXT2-2BAV4
37. M2333 s Hybrid 614 A1B1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
38. R2333s0 s NucA /Ensmbl 614 A1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
39. H2338 * h Prot 1050 A1B1C1D1 2026-05-14 2026-05-17 2026-05-21 2026-05-29 from: 2026-05-29
to: 2026-06-01
Factor XIa antibody complex 9933
40. M2334 s Hybrid 1204 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
41. R2334 s NucA /Ensmbl 609 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
42. T2313 * h Prot 618 A3 2026-05-14 2026-05-17 2026-05-28 2026-05-28 from: 2026-05-28
to: 2026-05-31
P66
43. H2339 * h Prot 1044 A1B1C1D1 2026-05-15 2026-05-18 2026-05-22 2026-05-30 from: 2026-05-30
to: 2026-06-02
Factor XIa antibody complex 7508
44. M2337 s Hybrid 644 A1B1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
45. R2336 s NucA /Ensmbl 644 A1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron precat
46. R2337s0 s NucA /Ensmbl 644 A1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
47. H1340 h Prot 686 UNK 2026-05-18 2026-05-21 2026-06-01 2026-06-01 - Parahenipavirus F protein /antibody complex
48. H1343 h Prot 773 UNK 2026-05-18 2026-05-21 2026-06-01 2026-06-01 - Hepatitis C Virus sE2 CBH-4G Fab complex
49. R2341 h NucA 186 A1 2026-05-18 2026-05-20 2026-06-01 2026-06-01 from: 2026-06-01
to: 2026-06-04
RRE core
50. H2319 * h Prot 497 A2B2C2 2026-05-19 2026-05-22 2026-06-02 2026-06-02 from: 2026-06-02
to: 2026-06-05
Human astrovirus VA1 capsid spike - antibody 7C8 complex
51. T1342 h Prot 1455 UNK 2026-05-19 2026-05-22 2026-06-02 2026-06-02 - Spike glycoprotein ectodomain
52. H1344 h Prot 734 UNK 2026-05-20 2026-05-23 2026-06-03 2026-06-03 - HSV gD - HAB72
53. H2321 * h Prot 502 A2B2C2 2026-05-20 2026-05-23 2026-06-03 2026-06-03 from: 2026-06-03
to: 2026-06-06
Human astrovirus VA1 capsid spike - antibody 2A2 complex
54. H1346 h Prot 885 UNK 2026-05-21 2026-05-24 2026-06-02 2026-06-04 - REGN3753 Fab-Fab complex
55. H1347 h Prot 876 UNK 2026-05-21 2026-05-24 2026-06-02 2026-06-04 - REGN15499 Fab-Fab complex
56. R2345 s NucA 64 A1 2026-05-21 2026-05-23 2026-06-04 2026-06-04 - R10C03
57. H1348 h Prot 1034 UNK 2026-05-22 2026-05-25 2026-06-03 2026-06-05 - gp130 antibody complex
58. H1349 h Prot 1030 UNK 2026-05-22 2026-05-25 2026-06-03 2026-06-05 - gp130 antibody complex
59. H1354 h Prot 726 UNK 2026-05-25 2026-05-28 2026-06-06 2026-06-08 - hemagglutinin/antibody
60. H1355 h Prot 708 UNK 2026-05-25 2026-05-28 2026-06-06 2026-06-08 - hemagglutinin/antibody
61. R2350 h NucA 389 A1 2026-05-25 2026-05-27 2026-06-06 2026-06-08 from: 2026-06-08
to: 2026-06-11
Tetrahymena Ribozyme C7.2 mutant RNA
62. H1356 h Prot 590 UNK 2026-05-26 2026-05-29 2026-06-07 2026-06-09 - A0A517IGU2, A0A517I5H8
63. R2351 h NucA 389 A1 2026-05-26 2026-05-28 2026-06-07 2026-06-09 from: 2026-06-09
to: 2026-06-12
Tetrahymena Ribozyme R1 mutant RNA
64. T1357 h Prot 196 UNK 2026-05-26 2026-05-29 2026-06-07 2026-06-09 - A7XX72_BP234
65. H1359 h Prot 2336 UNK 2026-05-27 2026-05-30 2026-06-08 2026-06-10 - A0AB35JLN2, A0AAE5SBF7, A0A2S4JD57, A0A0Q0BBX2, A0A1A6E3L8, A0ABT2VBN8
66. H2335 * h Prot 1820 A1B1C1D1E1 2026-05-27 2026-05-30 2026-06-10 2026-06-10 from: 2026-06-10
to: 2026-06-13
HCMV Merlin gHgLgO-Fab complex
67. R2352 h NucA 389 A1 2026-05-27 2026-05-29 2026-06-08 2026-06-10 from: 2026-06-10
to: 2026-06-13
Tetrahymena Ribozyme IC3 mutant RNA
68. T1358 h Prot 151 UNK 2026-05-27 2026-05-30 2026-06-08 2026-06-10 - A7XXF0_BP234
69. H1360 h Prot 1558 UNK 2026-05-28 2026-05-31 2026-06-09 2026-06-11 - P69905, P68871
70. R2353 h NucA 394 A1 2026-05-28 2026-05-30 2026-06-09 2026-06-11 from: 2026-06-11
to: 2026-06-14
Tetrahymena Ribozyme Vc2 mutant RNA
71. T1361 h Prot 123 UNK 2026-05-28 2026-05-31 2026-06-09 2026-06-11 - ProteinMPNN mutated bromodomain of PF3D7_1033700 (PfBDP1-BRD); Q8IJ72
72. H1362 h Prot 1836 UNK 2026-05-29 2026-06-01 2026-06-10 2026-06-12 - HCMV with a FAB
73. T1363 h Prot 170 UNK 2026-05-29 2026-06-01 2026-06-10 2026-06-12 - O36551
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2026, University of California, Davis
Terms of Use